https://www.rtvnoord.nl/nieuws/220259/RUG-onderzoeker-ontwikkelt-coronamedicijn-door
Google translate: Researcher Paul Hagedoorn of the University of Groningen may have developed a drug that works against malaria, and possibly corona, in such a way that it can be inhaled.
The drug may be available in four weeks, according to the Ukrant. Hagedoorn, together with professor of pharmacy Erik Frijlink, came up with the idea that two anti-malaria medicines could be processed in such a way that they could be taken with an inhaler.
To make the substances suitable as a medicine, it must be reduced. "As if you have to shrink a grain of sugar 25 million times," Hagedoorn said in the university newspaper. Protects and heals
Hagedoorn has indicated that it wants to use the medicine as quickly as possible for care providers, because according to Hagedoorn it also protects medicine 'and not only heals it'.
Frijlink previously said in the Dagblad van het Noorden that much remains to be done before the drug can be used. "Much remains to be done." Nor can the product be used just like that. "We must first make sure that it can be safely inhaled. ... If the volunteers immediately get lung complaints, it will not work."
Update: this message first incorrectly stated that Hagedoorn had developed the drug. It is about the way of administering an existing medicine.
RTV Noord looks like a legit regional news site, so hopefully this is legit. It will mean much faster effectiveness of treatment, and probably less dosage, too, since y'all keep posting that crap about macular degeneration.
Google translate: Researcher Paul Hagedoorn of the University of Groningen may have developed a drug that works against malaria, and possibly corona, in such a way that it can be inhaled.
The drug may be available in four weeks, according to the Ukrant. Hagedoorn, together with professor of pharmacy Erik Frijlink, came up with the idea that two anti-malaria medicines could be processed in such a way that they could be taken with an inhaler.
To make the substances suitable as a medicine, it must be reduced. "As if you have to shrink a grain of sugar 25 million times," Hagedoorn said in the university newspaper. Protects and heals
Hagedoorn has indicated that it wants to use the medicine as quickly as possible for care providers, because according to Hagedoorn it also protects medicine 'and not only heals it'.
Frijlink previously said in the Dagblad van het Noorden that much remains to be done before the drug can be used. "Much remains to be done." Nor can the product be used just like that. "We must first make sure that it can be safely inhaled. ... If the volunteers immediately get lung complaints, it will not work."
Update: this message first incorrectly stated that Hagedoorn had developed the drug. It is about the way of administering an existing medicine.
RTV Noord looks like a legit regional news site, so hopefully this is legit. It will mean much faster effectiveness of treatment, and probably less dosage, too, since y'all keep posting that crap about macular degeneration.
